DaVita HealthCare Partners

DaVita HealthCare Partners

Yahoo Finance • 9 hours ago

1 Mid-Cap Stock to Target This Week and 2 Facing Headwinds

1 Mid-Cap Stock to Target This Week and 2 Facing Headwinds Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in fro... Full story

Yahoo Finance • 12 days ago

3 Cash-Producing Stocks with Open Questions

3 Cash-Producing Stocks with Open Questions A company that generates cash isn't automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not all companies are created equal, an... Full story

Yahoo Finance • 18 days ago

1 Profitable Stock with Competitive Advantages and 2 That Underwhelm

1 Profitable Stock with Competitive Advantages and 2 That Underwhelm Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn't mean it... Full story

Yahoo Finance • 26 days ago

DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors

DaVita HealthCare (DVA) ended the recent trading session at $193.86, demonstrating a +1.55% change from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily loss of 0.45%. Meanwhile, the Dow lost 1.21... Full story

Yahoo Finance • last month

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now

DaVita Inc. DVA has been gaining from strong execution across its Integrated Kidney Care (IKC) platform, improving treatment volumes and investments in technology and clinical innovation. The optimism is led by solid first-quarter 2026 res... Full story

Yahoo Finance • last month

3 Reasons to Sell DVA and 1 Stock to Buy Instead

3 Reasons to Sell DVA and 1 Stock to Buy Instead DaVita's 20.6% return over the past six months has outpaced the S&P 500 by 7%, and its stock price has climbed to $183.98 per share. This performance may have investors wondering how to app... Full story

Yahoo Finance • last month

Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks

[Health Care Medical Concept] ogichobanov/iStock via Getty Images The healthcare sector (XLV [https://seekingalpha.com/symbol/XLV]) gained 4.91% in August, outperforming the broader S&P 500 (SPY [https://seekingalpha.com/symbol/SPY]), whi... Full story

Yahoo Finance • last month

Why Is Encompass Health (EHC) Down 1.8% Since Last Earnings Report?

It has been about a month since the last earnings report for Encompass Health (EHC). Shares have lost about 1.8% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings rele... Full story

Yahoo Finance • last month

3 of Wall Street’s Favorite Stocks We Find Risky

3 of Wall Street's Favorite Stocks We Find Risky Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it's worth remembering that analysts rarely issue s... Full story

Yahoo Finance • last month

Can Fresenius Medical's 5008X Rollout Drive the Next Growth Phase?

Fresenius Medical Care AG FMS is accelerating the U.S. rollout of its 5008X CAREsystem as it pushes high-volume hemodiafiltration, or HVHDF, into more clinics. The deployment adds a technology-led growth avenue across both services and pro... Full story

Yahoo Finance • last month

1 Value Stock with Impressive Fundamentals and 2 Facing Headwinds

1 Value Stock with Impressive Fundamentals and 2 Facing Headwinds The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap asse... Full story

Yahoo Finance • 2 months ago

How CVS' Pharmacy & Consumer Wellness Is Positioned for H2 2026

CVS Health CVS is building strong momentum in its Pharmacy and Consumer Wellness segment. The segment's broad footprint, as of June 30, 2026, includes nearly 9,000 retail locations, online retail pharmacy websites, retail specialty pharmac... Full story

Yahoo Finance • 2 months ago

Alebund Pharmaceuticals Announces 2026 Interim Results

SHANGHAI, Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a renal-focused biopharmaceutical company, today announced its unaudited consolidated interim results for... Full story

Yahoo Finance • 2 months ago

Can Humana (HUM) Stay Cheap If Medicare Advantage Margins Tighten?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Humana stock has delivered a strong 46.2% return year to date, yet the valuation checks paint a... Full story

Yahoo Finance • 2 months ago

Berkshire Hathaway boosted stake in Alphabet, homebuilders in the second quarter

Berkshire Hathaway is increasing the size of its stake in Google's parent company and beefing up its holdings in homebuilders, according to the conglomerate's latest snapshot of its investment portfolio. The Omaha, Nebraska-based company... Full story

Yahoo Finance • 2 months ago

Berkshire ups Alphabet stake under Greg Abel, making it a top-3 holding

Berkshire Hathaway (BRK-A, BRK-B), under new CEO Greg Abel, increased its Alphabet position, making the Google parent its third-largest U.S.-listed equity holding by market value, behind Apple (AAPL) and American Express (AXP). According t... Full story

Yahoo Finance • 2 months ago

Stock Indices Fall from Early Highs and Settle Mixed

The S&P 500 Index ($SPX) (SPY) on Wednesday closed down -0.17%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.49%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.83%.  September E-mini S&P futures (ESU26) fell -0.19%,... Full story

Yahoo Finance • 2 months ago

Stocks making the biggest moves premarket: SpaceX, AMD, Eli Lilly, Disney & more

Check out the companies making the biggest moves premarket: SpaceX — The Elon Musk-led rocket company fell 11% after releasing its first quarterly report since going public in June . SpaceX reported capital expenditures of $18.37 billion i... Full story

Yahoo Finance • 2 months ago

DaVita Inc (DVA) (Q2 2026) Earnings Call Highlights: Strong Volume Growth and Strategic ...

This article first appeared on GuruFocus. Adjusted Operating Income: $579 million in Q2 2026. Adjusted Earnings Per Share: $4.02 in Q2 2026. Free Cash Flow: $256 million in Q2 2026. U.S. Dialysis Treatment Volume Growth: Increased 56 basi... Full story

Yahoo Finance • 2 months ago

DaVita falls despite top and bottom line beats

[Q2 second quarter business report infographic data] cagkansayin * DaVita (DVA [https://seekingalpha.com/symbol/DVA]) is down ~7% in after-hours trading Tuesday despite releasing Q2 financial results that beat [https://seekingalpha.com/... Full story